Survival of prostate cancer and life expectancy for prostate cancer are like two sides of the same coin. One of them is completely dependent on the others. Each is unique in this world. Family history in relation to a specific disease, lifestyle, eating habits are all factors affecting survival and, of course, consequently, their life expectancy.

Virtually all experts believe that the health of early symptoms of cancer especially useful in combating metastasis (spread to other parts of the body) of cancer. If metastases, the survival of patients is questionable. I also believe that the biopsy is in patients over 70 also very harmful. This could have on life expectancy for prostate cancer.

Survival of prostate cancer, the effectiveness of the diagnosis. This is done by the classification and staging. In the method of staging four phases A, B, C and D were developed, depending on the severity of the disease. Phase A is the inclusion of prostate cancer, the stage of B-form palpable nodes, but restricted to the area of the prostate, stage C node distribution on site and date D cancer spreads to other parts called metastases. Stages A to D in the ascending scale on the gravity.

The extension of the Gleason system, is important for assessing the progression of prostate cancer. Gleason system uses a scale of 2-10. If the Gleason score of 6 or less cancer cells do not proliferate. A Gleason score of 7 is indicative of the formation of aggressive cells. All Gleason score 8-10 shows metastasis.

There really are ways to prevent the setting of prostate cancer to increase the survivability of prostate cancer? The answer is clearly no. There are several ways to reduce according to the researchers to the risk. Diet and lifestyle play a role in reducing the risk of prostate cancer. Exercise in fresh air with oxygen and a low fat diet can and rich in fruits, vegetables and maintaining a healthy weight also help the risk

To prolong the life expectancy for prostate cancer life expectancy treatment options are discussed. But the medical review boards, it takes 10 years to studies on a broad spectrum of patients, a costly proposal is complete. For example, increased research, the data from the past to compare the treatments. This is called a retrospective study and unreliable.